Loading ...
Sorry, an error occurred while loading the content.

Clinical Trials of Nabi Biopharmaceuticals' Civacir Commence

Expand Messages
  • claudine intexas
    Clinical Trials of Nabi Biopharmaceuticals Civacir Commence Beginning human trials of Civacir is an important corporate and clinical milestone for Nabi
    Message 1 of 1 , Apr 28, 2002
    • 0 Attachment
      Clinical Trials of Nabi Biopharmaceuticals' Civacir Commence
      "Beginning human trials of Civacir is an important corporate and
      clinical milestone for Nabi Biopharmaceuticals," said David J Gury,
      chairman, president and CEO.

      (To learn more about How Lymphocytes Produce Antibodies Visit
      CellsAlive.com)

      "There is a significant unmet medical need for this kind of product
      in liver transplant patients suffering from hepatitis C virus (HCV)
      infection. Re-infection by HCV is nearly universal in patients who
      have received liver transplants due to chronic HCV infection.
      Civacir, if successful in clinical trials and approved by FDA, would
      be the first therapy specifically developed to help protect patients
      from HCV following liver transplant surgery."

      The phase I/II study of Civacir is a randomized, controlled clinical
      trial and will evaluate two dose levels of Civacir. The clinical
      trial will evaluate the safety and antibody levels of Civacir, as
      well as its effects on the level of virus circulating in the
      patients' blood and in the transplanted livers.

      Results of a study in chimpanzees suggested that multiple infusions
      of Civacir were effective in the early termination of HCV infections
      in animals challenged with various doses of HCV as reported by Nabi
      on August 31, 1999.

      Timely expert analysis on key business issues. Find out more by
      visiting www.datamonitor.com


      __________________________________________________
      Do You Yahoo!?
      Yahoo! Health - your guide to health and wellness
      http://health.yahoo.com
    Your message has been successfully submitted and would be delivered to recipients shortly.